Welcome to LookChem.com Sign In|Join Free

CAS

  • or

79220-94-3

Post Buying Request

79220-94-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

79220-94-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 79220-94-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,2,2 and 0 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 79220-94:
(7*7)+(6*9)+(5*2)+(4*2)+(3*0)+(2*9)+(1*4)=143
143 % 10 = 3
So 79220-94-3 is a valid CAS Registry Number.

79220-94-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (K3519)  KRM-III  ≥98% (HPLC)

  • 79220-94-3

  • K3519-5MG

  • 1,153.62CNY

  • Detail
  • Sigma

  • (K3519)  KRM-III  ≥98% (HPLC)

  • 79220-94-3

  • K3519-25MG

  • 4,636.71CNY

  • Detail

79220-94-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,5-diphenyl-1H-imidazole-2-thione

1.2 Other means of identification

Product number -
Other names 1,4-diphenyl-1H-imidazole-2-thiol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:79220-94-3 SDS

79220-94-3Relevant articles and documents

T-CELL INHIBITING COMPOUNDS AND THEIR USE FOR THE TREATMENT OF T-CELL-MEDIATED DISEASES

-

Page/Page column 30, (2008/12/07)

The present invention relates to compounds of formula IA or IB. The present invention also concerned to a method of treating immunologic diseases or pathological conditions in association with T cell involving an immunologic component using T-cell inhibitors, optionally in combination with one or more other drugs selected from steroids, DMARDs, NSAIDs, immunosuppressive, and biological modifiers, pharmaceutical compositions comprising said compounds of formula IA or IB together with said other drugs, and the use of T-cell inhibitors for the manufacture of a pharmaceutical composition for the treatment of immunologic diseases or pathological conditions involving an immunologic component.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 79220-94-3